1 The effects of muscarinic receptor agonists on the electrically-evoked surface-negative field potential (N-wave) were measured in the guinea-pig olfactory cortex slice maintained in vitro.
Introduction
The possibility that muscarinic receptors might form a heterogeneous population has been extensively investigated (Hammer et al., 1980; Watson et al., 1983; Kubo et al., 1986) . Evidence suggests that there are at least two and possibly three muscarinic receptor subtypes (for recent review, see Eglen & Whiting, 1986) . Currently, one of the most selective agents able to distinguish between these subtypes is pirenzepine which has a high affinity for the M,-receptor subtype (KD-10-20 nM), but a lower affinity for M2-receptors (KD-200-800 nM) (Hammer et al., 1980; Hammer & Giachetti, 1982) . bral cortex, hippocampus and autonomic ganglia, while M2-receptors are found predominantly in lower brain areas and in peripheral tissues, such as autonomic effector organs and the myocardium (Watson et al., 1983; Mash & Potter, 1986) . Other antagonists appear to be more selective towards M2-receptors, e.g. gallamine and 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP; Barlow et al., 1976; Clark & Mitchelson, 1976; Berrie et al., 1983) . While some agonists also appear to be selective, evidence for this is less well established because of the difficulties of quantifying agonist effects (see Barlow, 1980) . Many authors have speculated on the possibilities of pharmacological exploitation of the subtle differences between muscarinic receptor subtypes to develop a treatment for Alzheimer's disease, a degenerative condition in which the cholinergic innerva-tion to the higher brain areas is disrupted (Whitehouse et al., 1981) . A selective Ml-receptor agonist might alleviate some of the worst symptoms of Alzheimer's disease without the unpleasant and dangerous peripheral side effects usually associated with muscarinic cholinomimetics. In spite of the potential therapeutic interest in muscarinic receptor subtypes, very few studies have attempted to characterize pharmacologically the Ml-receptor in intact brain tissue. Although the muscarinic receptor in sympathetic neurones of the superior cervical ganglion has been shown to be highly sensitive to the selective M1 antagonist pirenzepine (Brown et al., 1980) , several regions of the brain contain muscarinic receptors that are relatively insensitive to this antagonist, including locus coeruleus (Egan & North, 1985) and nucleus parabrachialis (Egan & North, 1986) . Very little is known about the muscarinic receptors found in the higher brain areas, areas more likely to be important in cognitive deficits. For this reason we chose to study the properties of muscarinic receptors in an in vitro cortical preparation, the olfactory cortex slice. This structure has a muscarinic receptor that can be studied with simple electrophysiological recording techniques (Williams et al., 1985) . In this paper, the general properties of the muscarinic response were investigated in detail, while in the accompanying paper (Williams & Constanti, 1988) a quantitative assessment of the receptor subtype mediating the response was attempted. Some of the present results have previously appeared in a preliminary form (Williams & Constanti, 1986 ).
Methods
Male guinea-pigs (200-400g) were decapitated and the brain quickly removed and placed into chilled Krebs solution (40C). Surface slices of olfactory cortex (-500pm thick) were cut manually with a bow cutter and recessed guide, as previously described (Harvey et al., 1974) . Slices were placed (pial surface uppermost) in a recording chamber, perfused at -5mlmin-' with oxygenated Krebs solution, and incubated for at least 2 h at 23-250C before recording was started. Bipolar platinum stimulating electrodes were placed on the severed (rostral) end of the lateral olfactory tract (LOT) and single supramaximal stimuli applied at 0.2 Hz (0.02-0.2 ms duration, 2-20 V). Surface field potential responses were measured from the prepiriform region using a low resistance (1-3 MQ) glass microelectrode (filled with 0.9% NaCl). The evoked field potential consisted of a lat ge surface negative wave (N-wave) representing summed superficial excitatory postsynaptic potentials, sometimes with positive notches (population spikes) and occasionally a positive-going P-wave (Richards & Sercombe, 1968; Harvey et al., 1974) . Signals were displayed and captured by use of a digital oscilloscope (Gould OS1420), and selected records played out at reduced speed on a Bryans 28000 chart recorder. Field potential peak negativity was continuously monitored by the sample-and-hold circuit of a peak height detector (Courtice, 1977) 
Results

Effects ofmuscarinic agonists
Bath-superfusion of (± )-muscarine or 'mixed' cholineoceptor agonists depressed the amplitude of the recorded field potential, an effect shown previously to be mediated probably through a presynaptic muscarinic receptor (Williams et al., 1985) . An example of this effect is shown in Figure 1 in which 100,uM carbachol (CCh) was applied for 2min. The field potential was clearly depressed by CCh ( Figure  la , centre trace). Although this effect was reversible on washout of the agonist, recovery was typically slow as shown in the chart record of peak N-wave amplitude ( Figure lb ). Responses to muscarinic agonists were also rather slow to develop compared with amino acid responses (Brown & Galvan, 1979) and usually the peak response to the agonists was seen after the 2min superfusion period. Longer drug applications gave larger responses, but the effects were prolonged and often showed incomplete recovery. A 'compromise' dose contact time of 2 min was therefore regularly employed.
Reproducibility ofagonist responses
In view of the prolonged recovery time necessary for agonist responses, it was important to check that reproducible responses could be evoked over many hours. In the experiment shown in Figure (Figure 3) , suggesting that prolonged application of at least low agonist doses did not induce desensitization. However, it was possible that larger doses might induce some desensitization. Indeed, the experiments performed to determine the optimal contact time showed that long application times of large agonist doses did reduce the sensitivity of the slice to later doses; this could however, reflect a fairly long-term loss of sensitivity, rather than a classical desensitization. 
Effects of temperature
Brain slice studies are often conducted at temperatures lower than 370C, so that oxygen tension is maintained in all parts of the slice (Harvey et al., 1974) . To check that the muscarinic response was not substantially different at the lower temperature used in this study, responses to CCh were compared at 240C and 370C (Figure 3c ). It was noted that CCh was slightly less potent at the higher temperature and that the rates of onset and washout of responses were more rapid. However, at 37'C, field potential amplitudes often showed a sudden irreversible decline during the experiment, probably due to progressive anoxia in the slice (Fujii et al., 1982) . This phenomenon was also seen in slices that had not received any drug applications. In view of the poor long-term survivability of slices at physiological temperatures we chose to conduct the present experiments at 23-250C.
Agonist dose-response relationships Acetylcholine (ACh) and methacholine (MCh) produced identical effects to CCh (Figure 4 ), but only in the presence of an anticholinesterase (the olfactory cortex is rich in acetylcholinesterase; Wenk et al., 1977 Neostigmine had no effect on responses to CCh, and in no case was any effect observed when neostigmine was applied alone. Application of (±)-muscarine produced similar effects to the choline esters. The amplitude of the evoked field potential in the olfactory slice is fairly constant in individual slices but shows considerable variation between slices. Agonist responses were therefore expressed as a percentage depression of the control field potential peak negativity, measured just before drug application. In a few experiments the effects of agonists on both peak negativity and also the area of the field potential beneath the baseline (time integral) were measured. However, both techniques yielded very similar estimates of response size. Similarly, the effects of agonists on the rate of rise of the N-wave were identical in magnitude to the effects on peak negativity. In a small but significant number of cases, measurements were complicated by the presence of a large population spike that obscured the peak of the N-wave. These results were not included in quantitative analyses.
Log-dose response relationships for CCh, ACh, MCh and muscarine were constructed by pooling data from 5 to 18 slices ( Figure 5) (Figure 4c ), but full quantification was not attempted because of the limited availability of this compound.
Low potency agonists
Both bethanechol, a choline ester that is relatively I/ s / bselective for muscarinic receptors (see Gilman et al., 1985) , and pilocarpine were found to have a low potency when applied to the olfactory slice and were only significantly active at mm concentrations ( Figure 6 ). Neither agonist evoked a maximum response at doses up to 10mm. Some experiments were also attempted with McN-A-343, a muscarinic ganglion stimulant with a suggested selectivity towards Ml-receptors (Hammer & Giachetti, 1982 (Takeyasu et al., 1979) , myenteric plexus (Morita et al., 1982) and against the dose-response relationships showing the slow calcium-dependent afterhyperpolarization in ,n percentage depression of peak N-wave the olfactory cortex (Constanti & Sim, 1987b 7c). The threshold oxotremorine dose at which antagonism became detectable was around 1 gM. The actions of oxotremorine therefore appeared to mimic those of a reversible competitive antagonist and these properties were further investigated in the accompanying paper (Williams & Constanti, 1988) .
Discussion
The present results show that clearly reproducible and dose-dependent responses to muscarinic agonists can be measured in the olfactory cortex slice, provided an adequate dose interval (at least 45 min) is employed. Agonist potencies for muscarine and active choline esters were low compared with values measured on smooth muscle and autonomic ganglia (Furchgott & Bursztyn, 1967; Burgen & Spero, 1968; Brown et al., 1980) but similar to those found in other brain areas (Halliwell & Adams, 1982; Dodt & Misgeld, 1986) and in a previous intracellular study of olfactory neuronal responses to muscarinic agonists (Constanti & Galvan, 1983) . This slightly lower potency of agonists in the olfactory slice may be a reflection of poor drug access, a particular problem in this preparation (Galvan, 1979 (Birdsall et al., 1978) and the values for stimulation of phospholipid turnover in the cerebral cortex (Fisher et al., 1983; Jacobson et al., 1985) ; such comparisons should however, be treated with caution, since there is no evidence to suggest that the muscarinic response in this study is mediated by phospholipid turnover. Another difficulty with these comparisons is that agonist responses are often complex and potency measurements may vary according to which component of the response is measured e.g. binding and efficacy are not equivalent (Stephenson, 1956) . No evidence was found to suggest that the muscarinic depression of the field potential underwent a 'fade' or tachyphylaxis. This observation agrees with that of Brown et al., (1980) in the rat superior cervical ganglion where no overt desensitization to muscarinic agonists was seen. The slow nature of the responses however, made it difficult to determine if high agonist doses would elicit rapid desensitization. In contrast to the rat ganglion, a long-term loss of sensitivity was observed for prolonged application of higher agonist doses.
The poor efficacy of pilocarpine and bethanechol may reflect a partial agonist action as seen in sympathetic ganglia (Burgen & Spero, 1968; Brown et al., 1980) , parasympathetic postganglionic neurones (Goyal & Rattan, 1978) , embryonic chick limb bud cells (Schmidt et al., 1984) , the phosphoinositide response in the brain (Fisher et al., 1983 ) and the inhibition of stimulated cyclic AMP formation in neuroblastoma cells (McKinney et al., 1985) . These agonists are generally considered to show little or no activity at nicotinic receptors in ganglia (Caulfield & Stubley, 1982; Gilman et al., 1985) or skeletal muscle (Clague et al., 1985) . The likelihood that pilocarpine and bethanechol were partly acting on cortical nicotinic receptors in our experiments, therefore seems remote. Indeed, millimolar concentrations of nicotinic agonists have little effect on the olfactory cortical N-wave (Williams et al., 1985) . A possible effect of pilocarpine exerted via histamine receptors also seems unlikely, since histamine (up to 1 mM) does not influence N-wave amplitude (Galvan, 1979) .
The finding that oxotremorine behaved as an antagonist (see Williams & Constanti, 1987) was rather unexpected in view of its reported high agonist potency in evoking other types of muscarinic responses (Takeyasu et al., 1979; Morita et al., 1982; Ringdahl, 1984) . For example, oxotremorine (0.5-10 uM) is a potent inhibitor of the outward membrane current underlying the slow afterhyperpolarization in olfactory neurones, acting via a postsynaptic M2-type muscarinic receptor (Constanti & Sim, 1987b) . On some tissues however, oxotremorine can show little or no agonist effectiveness; e.g. it acts as a partial agonist on sympathetic ganglia (Brown et al., 1980) , a competitive antagonist of the muscarinic rise in cyclic GMP levels in neuroblastoma cells (McKinney et al., 1985) and a blocker of carbachol-induced phospholipid turnover in brain synaptosomes (Fisher et al., 1983) .
In a previous paper (Williams et al., 1985) , we showed that the muscarinic depression of the field potential was not apparently mediated by a decrease in presynaptic LOT fibre tract excitability, nor via a synaptically released inhibitory neurotransmitter such as y-aminobutyric acid (GABA) or adenosine. The action of muscarinic agonists could also not be explained by a reduction in postsynaptic M-current (IM; Constanti & Galvan, 1983) , since barium, a known blocker of this current, did not depress the N-wave potential (Williams, 1986) . Indeed, muscarinic suppression of IM appears to involve an M2-type receptor, showing only a low sensitivity to pirenzepine (Constanti & Sim, 1987a) . It therefore seems likely that the responses observed in the present study were mediated via a distinct presynaptic muscarinic receptor.
Although the muscarinic ganglion stimulant McN-A-343 is claimed to be a selective Ml-receptor agonist (Hammer & Giachetti, 1982; Birdsall et al., 1983) , several studies show that it is either not very selective towards M1-and M2-receptors or that it appears not to act exclusively through muscarinic receptors (Murayama & Unna, 1963; Brown et al., 1980; North et al., 1985) . Our own results, although somewhat limited, tend to support the idea that McN-A-343 is not a very selective muscarinic agonist.
In conclusion, we have shown that quantifiable responses to muscarinic agonists can be elicited in the in vitro olfactory cortex slice, although agonist potencies may be somewhat underestimated. A quantitative investigation of muscarinic antagonist actions on this slice therefore appeared to be quite feasible (Williams & Constanti, 1988) .
